Compare CRC & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRC | MMED |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | United States | United States |
| Employees | 2500 | 2800 |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.3B |
| IPO Year | N/A | 2026 |
| Metric | CRC | MMED |
|---|---|---|
| Price | $53.28 | $16.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $72.57 | $22.56 |
| AVG Volume (30 Days) | 800.9K | ★ 1.1M |
| Earning Date | 05-05-2026 | 06-03-2026 |
| Dividend Yield | ★ 2.38% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.37 | $15.99 |
| Revenue Next Year | N/A | $10.00 |
| P/E Ratio | $13.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $43.25 | $10.65 |
| 52 Week High | $71.98 | $17.86 |
| Indicator | CRC | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 46.33 | 66.74 |
| Support Level | $50.46 | $14.70 |
| Resistance Level | $54.00 | N/A |
| Average True Range (ATR) | 1.39 | 0.85 |
| MACD | 0.41 | 0.12 |
| Stochastic Oscillator | 80.26 | 78.65 |
California Resources Corp is an independent oil and natural gas exploration and production company. The company has operations spread across different properties in several oil and gas exploration basins in California and Utah, such as the Midway-Sunset, South Belridge, and McKittrick fields, in the San Joaquin Basin, and other properties located in Los Angeles, Sacramento, Uinta, and the Ventura and Salinas basins. Additionally, the company is focused on maximizing the value of its land, mineral ownership, and energy expertise for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects. Its business is organized into two reporting segments: oil and natural gas, which generate maximum revenue, and carbon management.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.